Journal
EXPERT OPINION ON THERAPEUTIC TARGETS
Volume 12, Issue 6, Pages 749-756Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1517/14728222.12.6.749
Keywords
cancer; immunotherapy; mucosa antigens; tumor antigens; tumor vaccines
Categories
Ask authors/readers for more resources
Background: Prevention and treatment of human cancer through immunotherapy has been difficult owing to lack of a specific target and poor immunity. It is of no surprise that cancer mucosa antigens (CMAs) may serve as attractive targets for cancer immunotherapy. Objective: To present and discuss the current state of the research on CMAs. Methods: We review the evidence that a number of CMAs have been used to augment immune responses against cancer and that some progress has been made. We envisage future developments toward identifying CMAs and their potential applications to cancer treatment. Results/conclusion: CMAs may reasonably be considered as novel targets for immunotherapy. More investigations should be performed to improve the success of immunotherapy in clinical trials.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available